2 months ago
MAZE
AnalystsDebjit ChattopadhyayDebjit Chattopadhyay's Stock Forecasts
AnalystsDebjit Chattopadhyay
Sectors:
Industries:
Analyst Ranking
Top 15%
#790 out of 5263 analysts
Average Return
+8.79%
Win Rate
52%55 out of 105
Risk vs Reward
Poor
Good
Debjit Chattopadhyay's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Maze Therapeutics IncMAZE | +328.57% | $10.57 | $45.30 | 2025-02-24 - 2026-02-24 | Strong Buy |
Maze Therapeutics IncMAZE | +180.14% | $10.37 | $29.05 | 2025-04-01 - 2026-04-01 | Strong Buy |
Jounce Therapeutics IncJNCE | +158.50% | $4.94 | $12.77 | 2020-03-01 - 2021-03-02 | Buy |
Ionis Pharmaceuticals IncIONS | +135.98% | $31.71 | $74.83 | 2025-04-30 - 2026-04-29 | Strong Buy |
Sarepta Therapeutics IncSRPT | +134.33% | $55.25 | $129.47 | 2017-11-30 - 2018-11-30 | Buy |
Debjit Chattopadhyay Analyst Color
Get additional color on Debjit Chattopadhyay's coverage of popular stocks
2 months ago
KRYS
2 months ago
NAMS
2 months ago
PEPG
5 months ago
CNTA
7 months ago
QURE
7 months ago
IONS
7 months ago
MAZE
2 years ago
DYN
2 years ago
KRYS
Debjit Chattopadhyay's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Satellos Bioscience IncMSLE | 1 | Strong Buy | $23.00 | +216.37% | Initiates Coverage On | 2 days ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $26.00 | +268.79% | Initiates Coverage On | a month ago |
Maze Therapeutics IncMAZE | 4 | Strong Buy | $58.00 | +125.86% | Maintains | 2 months ago |
Krystal Biotech IncKRYS | 5 | Strong Buy | $284.00 | +9.25% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $86.00 | +58.64% | Maintains | 2 months ago |
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $45.00 | +58.28% | Maintains | 2 months ago |
Pepgen IncPEPG | 3 | Strong Buy | $7.00 | +351.61% | Maintains | 2 months ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $20.00 | +57.23% | Initiates Coverage On | 3 months ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Strong Buy | $52.00 | +115.05% | Maintains | 4 months ago |
Rezolute IncRZLT | 3 | Strong Buy | $6.00 | +92.31% | Maintains | 5 months ago |
Pharvaris NvPHVS | 1 | Strong Buy | $39.00 | +30.74% | Maintains | 5 months ago |
Centessa Pharmaceuticals PLCCNTA | 7 | Strong Buy | $43.00 | +9.00% | Maintains | 5 months ago |
Sarepta Therapeutics IncSRPT | 7 | Strong Buy | $19.00 | -8.08% | Maintains | 6 months ago |
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $30.00 | +428.17% | Initiates Coverage On | 7 months ago |
Uniqure NvQURE | 5 | Strong Buy | $95.00 | +467.84% | Maintains | 7 months ago |
Ionis Pharmaceuticals IncIONS | 5 | Strong Buy | $92.00 | +22.95% | Maintains | 7 months ago |
Soleno Therapeutics IncSLNO | 5 | Strong Buy | $106.00 | +100.83% | Reiterates | 8 months ago |
Passage Bio IncPASG | 3 | Strong Buy | $10.00 | +86.92% | Maintains | 9 months ago |
Intellia Therapeutics IncNTLA | 3 | Strong Buy | $14.00 | +12.49% | Maintains | 9 months ago |
Vertex Pharmaceuticals IncVRTX | 6 | Strong Buy | $546.00 | +29.00% | Maintains | 9 months ago |
Dyne Therapeutics IncDYN | 4 | Strong Buy | $50.00 | +187.19% | Reiterates | 10 months ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $55.00 | +87.20% | Maintains | a year ago |
Prime Medicine IncPRME | 3 | Strong Buy | $18.00 | N/A | Reiterates | a year ago |
Benitec Biopharma IncBNTC | 2 | Strong Buy | $17.00 | N/A | Reiterates | a year ago |
Amicus Therapeutics IncFOLD | 2 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Precision Biosciences IncDTIL | 2 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Allogene Therapeutics IncALLO | 1 | Buy | $29.00 | N/A | Maintains | 3 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Tourmaline Bio IncTRML | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Strong Buy | $255.00 | N/A | Initiates Coverage On | 5 years ago |
Galapagos NvGLPG | 3 | Hold | $123.00 | N/A | Downgrades | 6 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Tectonic Therapeutic IncTECX | 3 | Hold | $156.00 | N/A | Downgrades | 6 years ago |
Zymeworks IncZYME | 1 | Buy | $60.00 | N/A | Reiterates | 6 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $10.00 | N/A | Reiterates | 6 years ago |
Wave Life Sciences LtdWVE | 1 | Buy | $20.00 | N/A | Maintains | 6 years ago |
Immunogen IncIMGN | 2 | Hold | $3.50 | N/A | Downgrades | 7 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Buy | $33.00 | N/A | Maintains | 8 years ago |
Global Blood Therapeutics IncGBT | 4 | Buy | $125.00 | N/A | Maintains | 8 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.